Mesa Laboratories, Inc.

NASDAQ:MLAB

Hardware, Equipment & Parts

Technology
$137.81 -0.16%

-$0.15 today

Market cap
$774.56M
Beta
0.93
P/E (TTM)
78.3
EPS (TTM)
$1.21
Dividend yield
0.68%
52W Low $55.45High $113.99

Volume 0.07M

Average 0.16M

MLAB Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

Mesa Laboratories, Inc.NASDAQ: MLAB

Accounts Payables · Q4 FY2026 · quarter ended Mar 2026

Accounts payables turns negative

Q4 FY2026 accounts payables was -$324K, compared with $1.53M a year earlier. Trailing-twelve-month accounts payables was -$1.2M. Over 3 fiscal years it compounded at -8.2% a year.

Context

  • Accounts payables amounted to 0.5% of revenue in FY2026, up 0.3 pp from a year earlier.
  • Accounts payables grew in size in 2 of the last 3 fiscal years.

What to watch

Whether quarterly accounts payables holds near -$324K or moves back toward the trailing-twelve-month quarterly average of -$299.25K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$324K-361.3% QoQ
Last fiscal yearMar 2026
-$1.2M+208.5% YoY
LTMMar 2026
-$1.2M+208.5% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-121.2%——
1 year+208.5%——
3-year CAGR-8.2%——
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2026
(1.2M) USD
Year-over-year change
-208.5%

Accounts Payables vs competitors

How MLAB compares with its peers on the latest reported figures

  • MLAB's LTM Mar 2026 accounts payables of $1.2M is the 7th largest of the 11 companies compared; the peer median is $443K.
  • Its year-over-year change of +208.5% is the 3rd highest of 11, against a peer median of -48.2%.
  • Accounts payables amounts to 0.5% of revenue for MLAB, versus a peer median of 0.5%.
MLAB Competitors Peer median
Accounts Payables for MLAB and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AAgilent Technologies, Inc.LTM Jul 2026$70M +483.3%-49.1%0.9%
BIOBio-Rad Laboratories, Inc.LTM Jun 2026$34.6M +142.0%-89.8%1.3%
TECHBio-Techne CorporationLTM Sep 2026$24.54M +575.7%—2.0%
RVTYRevvity, Inc.LTM Jul 2026$14M -6266.1%—0.5%
TXG10x Genomics, Inc.LTM Jun 2026$2.46M +144.1%—0.4%
QGENQiagen N.V.LTM Jun 2026$1.56M -130.5%+68.6%0.1%
MLABMesa Laboratories, Inc.LTM Mar 2026$1.2M +208.5%-8.2%0.5%
MRVIMaravai LifeSciences Holdings, Inc.LTM Jun 2026$1.15M -14.3%+67.0%0.6%
LABStandard BioTools Inc.LTM Mar 2026$571K -82.0%—0.7%
PACBPacific Biosciences of California, Inc.LTM Mar 2026$315K -95.3%+34.3%0.2%
TMOThermo Fisher Scientific Inc.LTM Sep 2026$0 -100.0%-13.4%0.0%
Peer median (excluding MLAB) $443K-48.2%+10.4%0.5%

Competitors are the stored peer set for MLAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Net Income1.87M930K(254.25M)(1.97M)6.71M
Depreciation & Amortization25.07M33.13M31.57M24.53M23.27M
Deferred Income Tax128K(3.49M)(28.42M)(72K)(1.29M)
Stock-Based Compensation11.39M12.54M11.94M13.14M17.87M
Change in Working Capital(7.19M)(17.11M)5.97M6.9M(4.99M)
Accounts Receivables(6.75M)(2.12M)4.94M(2.93M)(3.21M)
Inventory(1.05M)(10.18M)2.56M1.15M(4.43M)
Accounts Payables1.37M(1.55M)(97K)(388K)(1.2M)
Other Working Capital(765K)(3.26M)(1.43M)9.06M3.85M
Other Non-Cash Items7.96M1.99M277.32M4.28M1.26M
Operating Cash Flow39.22M27.98M44.13M46.81M42.83M
Capital Expenditures(4.43M)(4.54M)(2.57M)(4.5M)(3.25M)
Acquisitions (Net)(300.79M)(4.95M)(78.74M)00
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities000(250K)0
Investing Cash Flow(305.23M)(9.49M)(81.31M)(4.5M)(3.25M)
Debt Repayment49M(36M)37.5M(42.35M)(26.75M)
Common Stock Issued00000
Common Stock Repurchased00000
Dividends Paid(3.34M)(3.41M)(3.45M)(3.47M)(3.52M)
Other Financing Activities6.92M6.08M(1.22M)1.31M(11.58M)
Financing Cash Flow52.58M(33.33M)32.84M(44.51M)(41.85M)
Effect of Forex Changes(1.09M)(1.6M)(359K)1.31M1.88M
Net Change in Cash(214.52M)(16.44M)(4.7M)(893K)(393K)
Free Cash Flow34.79M23.44M41.57M42.31M39.58M

Mesa Laboratories, Inc.

NASDAQ:MLAB

Intrinsic Alpha fair value

Locked

Current Price

$137.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.